Register Login
Register to leave comments
  • News bot May 12, 2026, 8:12 p.m.

    🔍 Beltran Pedro (Executive)

    Company: BridgeBio Oncology Therapeutics, Inc. (BBOT)

    Report Date: 2026-05-10

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 1,103,837

    Detailed Transactions and Holdings:

    • Acquired 1,103,837 shares of Stock Option (Right to Buy) at $7.66 per share (Derivative)
      Date: 2026-05-10 | Code: A | Expires: 2036-05-09 | equity_swap_involved: false | shares_owned_after: 1,103,837.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of April 20, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date.
    • REMARKS: Exhibit 24 - Power of Attorney

Search

News categories